Correlation Between Pfizer and Xilio Development
Can any of the company-specific risk be diversified away by investing in both Pfizer and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Xilio Development, you can compare the effects of market volatilities on Pfizer and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Xilio Development.
Diversification Opportunities for Pfizer and Xilio Development
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and Xilio is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Pfizer i.e., Pfizer and Xilio Development go up and down completely randomly.
Pair Corralation between Pfizer and Xilio Development
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Xilio Development. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 6.74 times less risky than Xilio Development. The stock trades about -0.23 of its potential returns per unit of risk. The Xilio Development is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 103.00 in Xilio Development on August 28, 2024 and sell it today you would lose (15.00) from holding Xilio Development or give up 14.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Xilio Development
Performance |
| Timeline |
| Pfizer Inc |
| Xilio Development |
Pfizer and Xilio Development Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Xilio Development
The main advantage of trading using opposite Pfizer and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |